Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Gastrointestinal 1

Conditions

Muscular Atrophy 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 1Lymphoma, Non-Hodgkin 1ER+ and AR+ Breast Cancer 1Colorectal Neoplasms 1Cachexia 1

Interventions

Megestrol Acetate 6Standard of Care 3Exercise 3Physical Therapy Modalities 2Nutrition Assessment 2Infliximab 2Blood Specimen Collection 2testosterone enanthate 1remune 1ostarine 1olanzapine-fluoxetine combination 1irinotecan sucrosofate 1clazakizumab 1bermekimab 1anamorelin 1Sodium Chloride 1Radiotherapy 1Preoperative Exercise 1Powders 1Pentoxifylline 1Olanzapine 1Nandrolone Decanoate 1Mirtazapine 1Melatonin 1Megestrol 1Immunologic Techniques 1Ibuprofen 1High-Energy Shock Waves 1Ghrelin 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cachexia × ostarine × Clear all
NCT00467844 2014-07-11

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

GTx

Phase 2 Completed
159 enrolled 11 charts
GastrointestinalLymphoidThoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin, Muscular Atrophy, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡